Correlation Between Pliant Therapeutics and Cullinan Oncology
Can any of the company-specific risk be diversified away by investing in both Pliant Therapeutics and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pliant Therapeutics and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pliant Therapeutics and Cullinan Oncology LLC, you can compare the effects of market volatilities on Pliant Therapeutics and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pliant Therapeutics with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pliant Therapeutics and Cullinan Oncology.
Diversification Opportunities for Pliant Therapeutics and Cullinan Oncology
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between Pliant and Cullinan is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Pliant Therapeutics and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and Pliant Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pliant Therapeutics are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of Pliant Therapeutics i.e., Pliant Therapeutics and Cullinan Oncology go up and down completely randomly.
Pair Corralation between Pliant Therapeutics and Cullinan Oncology
Given the investment horizon of 90 days Pliant Therapeutics is expected to generate 0.74 times more return on investment than Cullinan Oncology. However, Pliant Therapeutics is 1.35 times less risky than Cullinan Oncology. It trades about -0.14 of its potential returns per unit of risk. Cullinan Oncology LLC is currently generating about -0.27 per unit of risk. If you would invest 1,486 in Pliant Therapeutics on August 28, 2024 and sell it today you would lose (140.00) from holding Pliant Therapeutics or give up 9.42% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Pliant Therapeutics vs. Cullinan Oncology LLC
Performance |
Timeline |
Pliant Therapeutics |
Cullinan Oncology LLC |
Pliant Therapeutics and Cullinan Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pliant Therapeutics and Cullinan Oncology
The main advantage of trading using opposite Pliant Therapeutics and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pliant Therapeutics position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.Pliant Therapeutics vs. Relay Therapeutics | Pliant Therapeutics vs. Stoke Therapeutics | Pliant Therapeutics vs. Black Diamond Therapeutics | Pliant Therapeutics vs. Arvinas |
Cullinan Oncology vs. Eliem Therapeutics | Cullinan Oncology vs. HCW Biologics | Cullinan Oncology vs. Scpharmaceuticals | Cullinan Oncology vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |